Related Experiment Video
Updated: Aug 16, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Acquired and Isolated Deficiencies in Factor VII
Background:
Acquired and isolated deficiencies in FVII are exceptional. They have mainly been reported during states of severe sepsis by the presence of proteases destroying the factor or neoplastic pathologies by the presence of an inhibitor. Consequently, very few cases have been published.
Methods And Results:
We report two cases of isolated and acquired deficiency of factor VII due to the presence of inhibitors which were related to bacterial sepsis in the first patient and to squamous cell carcinoma in the second patient, diagnosed in the Hematology Laboratory of the CHU Ibn Rochd.
Conclusions:
Factor VII deficiency is a rare and poorly described deficiency that can be acquired or constitutional. The search for anti-factor VII antibodies by diluted thromboplastin time should be requested depending on the clinical context.
Insights
Acquired factor VII deficiency is rare, often linked to sepsis or cancer. This study details two such cases, highlighting the importance of inhibitor screening in specific clinical contexts.
Area of Science:
- Hematology
- Coagulation Disorders
Background:
- Acquired factor VII deficiency is exceptionally rare.
- Previously reported cases are associated with severe sepsis or neoplastic pathologies.
- These deficiencies are typically caused by proteases or inhibitors.
Observation:
- This report details two distinct cases of acquired, isolated factor VII deficiency.
- Both cases involved the presence of factor VII inhibitors.
- The first patient's deficiency was linked to bacterial sepsis; the second to squamous cell carcinoma.
Findings:
- The study identified inhibitors against factor VII as the cause of deficiency in both patients.
- The underlying conditions were bacterial sepsis and squamous cell carcinoma, respectively.
- Diagnosis was confirmed in the Hematology Laboratory of CHU Ibn Rochd.
Implications:
- Factor VII deficiency can be acquired, not just constitutional.
- Screening for anti-factor VII antibodies is crucial in patients presenting with unexplained factor VII deficiency.
- Diluted thromboplastin time testing should be considered based on clinical suspicion.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Venous Thrombosis III: Interprofessional Care
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

